Beta Drugs Limited — Carboplatin Exporter Profile
Indian Pharmaceutical Exporter · #10 for Carboplatin · $1.1M export value · DGFT Verified
Beta Drugs Limited is the #10 Indian exporter of Carboplatin with $1.1M in export value and 102 verified shipments. Beta Drugs Limited holds a 1.6% market share in Carboplatin exports across 16 countries. The company exports 17 pharmaceutical products worth $7.8M across 5 therapeutic categories.
Beta Drugs Limited — Carboplatin Export Profile: Buyers & Destinations
Where Does Beta Drugs Limited Export Carboplatin?
| Country | Value | Shipments | Share |
|---|---|---|---|
| KENYA | $201.9K | 8 | 18.7% |
| TANZANIA | $183.8K | 11 | 17.1% |
| LEBANON | $180.3K | 9 | 16.7% |
| ETHIOPIA | $155.0K | 9 | 14.4% |
| MYANMAR | $127.5K | 13 | 11.8% |
| UZBEKISTAN | $113.4K | 18 | 10.5% |
| ZAMBIA | $29.8K | 1 | 2.8% |
| VENEZUELA | $25.5K | 10 | 2.4% |
| RWANDA | $15.8K | 2 | 1.5% |
| MAURITIUS | $15.7K | 6 | 1.5% |
Beta Drugs Limited exports Carboplatin to 16 countries. The largest destination is KENYA accounting for 18.7% of Beta Drugs Limited's Carboplatin shipments, followed by TANZANIA (17.1%) and LEBANON (16.7%). These destinations reflect Beta Drugs Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Carboplatin from Beta Drugs Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| TO THE ORDER OF | KENYA | $245.2K | 13 |
| EXPTRANS GMBH S.A.R.L. | LEBANON | $180.3K | 9 |
| GENERICS & SPECIALITIES LTD | TANZANIA | $115.8K | 4 |
| MEDIHERB LIFESCIENCES LLC | UZBEKISTAN | $113.4K | 18 |
| M/S AORTA COMPANY LIMITED | MYANMAR | $67.8K | 7 |
| AORTA COMPANY LIMITED | MYANMAR | $59.8K | 6 |
| GALAXY PHARMACEUTICAL LTD | KENYA | $50.0K | 1 |
| KAS MEDICS LIMITED | TANZANIA | $48.5K | 4 |
| AUGUSTA LIMITED | ZAMBIA | $29.8K | 1 |
| KAS MEDICS LTD | TANZANIA | $19.5K | 3 |
Beta Drugs Limited supplies Carboplatin to 25 buyers globally. The largest buyer is TO THE ORDER OF (KENYA), followed by EXPTRANS GMBH S.A.R.L. (LEBANON) and GENERICS & SPECIALITIES LTD (TANZANIA). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Carboplatin Export Value and How Much Does Beta Drugs Limited Contribute?
India exported $50.8M worth of Carboplatin through 3,637 shipments from 273 suppliers to 138 countries, serving 829 buyers globally. Beta Drugs Limited contributes $1.1M to this total, accounting for 1.6% of India's Carboplatin exports. Beta Drugs Limited ships Carboplatin to 16 countries through 25 buyers.
What Is the Average Shipment Value for Beta Drugs Limited's Carboplatin Exports?
Beta Drugs Limited's average Carboplatin shipment value is $10.9K per consignment, based on 102 shipments totaling $1.1M. The largest destination is KENYA (18.7% of Beta Drugs Limited's Carboplatin exports).
How Does Beta Drugs Limited Compare to Other Indian Carboplatin Exporters?
Beta Drugs Limited ranks #10 among 273 Indian Carboplatin exporters with a 1.6% market share. The top 3 exporters are FRESENIUS KABI ONCOLOGY LIMITED ($27.5M), INTAS PHARMACEUTICALS LIMITED ($4.9M), EUGIA PHARMA SPECIALITIES LIMITED ($3.3M). Beta Drugs Limited processed 102 shipments to 16 destination countries.
What Carboplatin Formulations Does Beta Drugs Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| ADCARB 450 MG (CARBOPLATIN INJECTION BP450MG/45ML) BATCH: BCPI2412YA, MFD: JUN-24, EXP: MAY-26 | $86.5K | 3 |
| ADCARB 150 MG (CARBOPLATIN INJECTION BP150MG/15ML) BATCH: BCPI2413ZA, MFD: JUN-24, EXP: MAY-26 | $68.5K | 4 |
| ADCARB 450MG (CARBOPLATIN 450MG / 45ML I | $65.3K | 2 |
| ADCARB 450MG CARBOPLATIN 450MG BATCH | $64.6K | 5 |
| ADCARB 450 MG CARBOPLATIN INJECTION BP (450MG/45ML) BATCH:BCPI2504YA, MFD: FEB-25, EXP: JAN-27 | $63.6K | 4 |
| ADCRAB 450MG CARBOPLATIN INJ BP 450 MG/4 | $50.0K | 1 |
| 4000 VIALS OF ADCRAB 450MG CARBOPLATIN I | $50.0K | 1 |
| ADCARB 450 MG (CARBOPLATIN INJ BP 450 MG/45 ML) BATCH: BCPI2403YA, MFD: FEB-24,EXP: JAN-26 | $50.0K | 1 |
| ADCARB 450MG CARBOPLATIN 450MG / 45ML BP | $45.0K | 4 |
| ADCARB 450 MG CARBOPLATIN INJECTION BP (450MG/45 ML) BATCH: BCPI2504YC, MFD: FEB-25, EXP: JAN-27 | $43.2K | 1 |
Beta Drugs Limited exports 65 distinct Carboplatin formulations including tablets, capsules, syrups, and combination drugs. The top formulation is ADCARB 450 MG (CARBOPLATIN INJECTION BP450MG/45ML) BATCH: BC with 3 shipments worth $86.5K.
How Does Beta Drugs Limited Compare to Nearest Carboplatin Exporters?
Exporters ranked immediately above and below #10 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 7 | KARDI TRADING PRIVATE LIMITED | $2.6M | 130 | 8 | $20.3K |
| 8 | NAPROD LIFE SCIENCES PRIVATE LIMITED | $2.6M | 64 | 11 | $40.8K |
| 10 | BETA DRUGS LIMITED ★ | $1.1M | 102 | 16 | $10.9K |
| 11 | PLEASANT EXPORTS | $1.1M | 24 | 1 | $44.7K |
| 9 | ACCURE LABS PRIVATE LIMITED | $950.0K | 19 | 1 | $50.0K |
Beta Drugs Limited ranks #10 among 273 Indian Carboplatin exporters. Average shipment value of $10.9K compared to the market average of $186.1K. The closest competitors by value are KARDI TRADING PRIVATE LIMITED and NAPROD LIFE SCIENCES PRIVATE LIMITED.
Which Indian Ports Ship Carboplatin Exports?
| Port | Shipments | % Share |
|---|---|---|
| DELHI AIR CARGO ACC (INDEL4) | 648 | 17.8% |
| SAHAR AIR | 519 | 14.3% |
| SAHAR AIR CARGO ACC (INBOM4) | 502 | 13.8% |
| DELHI AIR | 463 | 12.7% |
| HYDERABAD AIR | 126 | 3.5% |
| Bombay Air | 119 | 3.3% |
| Delhi Air | 104 | 2.9% |
| HYDERABAD ACC (INHYD4) | 99 | 2.7% |
What Other Oncology Products Does Beta Drugs Limited Export?
Beta Drugs Limited also exports these oncology products. Each links to the detailed product page.
About Beta Drugs Limited
Beta Drugs Limited exports 17 products worth $7.8M. Beyond Carboplatin, top products include Linagliptin, Sitagliptin, Capecitabine, Mercaptopurine, Vildagliptin. View the complete Beta Drugs Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Carboplatin — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Carboplatin shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Beta Drugs Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 102 individual customs records matching Beta Drugs Limited exporting Carboplatin, covering 65 formulations to 16 countries via 25 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 138+ countries, 829+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Carboplatin Export Data from Beta Drugs Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Beta Drugs Limited's Carboplatin exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Beta Drugs Limited
Full Company Profile →
17 products · $7.8M total trade · 5 categories
Carboplatin Stats
Company Overview
Top Products by Beta Drugs Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Beta Drugs Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Carboplatin. For current shipment-level data, contact TransData Nexus.